Regulation of hepatic cytochrome P-450 during infectious disease
- PMID: 1695539
- DOI: 10.1139/y90-119
Regulation of hepatic cytochrome P-450 during infectious disease
Abstract
During episodes of infectious disease the mixed function oxidase system is depressed and the capacity of the liver to metabolize drugs can be compromised in both animals and humans. The depression that occurs during viral infections is mediated via the production of interferon. This action of interferon requires the synthesis of an intermediate protein(s) yet to be identified. Using an oligonucleotide probe for a unique sequence in cytochrome P-450LA omega we have now shown that the mRNA for this isozyme is depressed following the administration of interferon inducers. The magnitude in the loss of mRNA corresponds to the magnitude of the loss in the levels of this isozyme. This depression is observed within 6 h of interferon exposure. It is concluded that the decrease in drug metabolism during viral infections is caused by an interferon-mediated loss in mRNA and subsequent cytochrome P-450 synthesis in the liver.
Similar articles
-
The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid.polycytidylic acid.Biochem Pharmacol. 1992 Aug 4;44(3):604-8. doi: 10.1016/0006-2952(92)90458-u. Biochem Pharmacol. 1992. PMID: 1380810
-
Alteration of drug biotransformation by interferon and host defence mechanism.Ann Acad Med Singap. 1991 Jan;20(1):13-8. Ann Acad Med Singap. 1991. PMID: 1709343
-
Dissociation of xanthine oxidase induction and cytochrome P450 depression during interferon induction in the rat.Biochem Pharmacol. 1993 Dec 3;46(11):2114-7. doi: 10.1016/0006-2952(93)90658-j. Biochem Pharmacol. 1993. PMID: 7505583
-
Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.Am J Ther. 2005 May-Jun;12(3):254-61. Am J Ther. 2005. PMID: 15891270 Review.
-
Cytochrome P-450 monooxygenases and interactions of psychotropic drugs.Int J Psychiatry Med. 1991;21(1):47-56. doi: 10.2190/U0BD-PVHW-BA01-A1D0. Int J Psychiatry Med. 1991. PMID: 2066257 Review.
Cited by
-
Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerations.Clin Pharmacokinet. 1997 May;32(5):368-81. doi: 10.2165/00003088-199732050-00003. Clin Pharmacokinet. 1997. PMID: 9160171 Review.
-
Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients.Dig Dis Sci. 2003 Apr;48(4):802-8. doi: 10.1023/a:1022861414826. Dig Dis Sci. 2003. PMID: 12741475
-
Effects of quercetin on CYP450 and cytokines in Aroclor 1254 injured endometrial cells of the pregnant rats.Biomed Res Int. 2014;2014:497508. doi: 10.1155/2014/497508. Epub 2014 Mar 10. Biomed Res Int. 2014. PMID: 24711995 Free PMC article.
-
Allergic adverse reactions to sulfonamides.Curr Allergy Asthma Rep. 2002 Jan;2(1):16-25. doi: 10.1007/s11882-002-0033-y. Curr Allergy Asthma Rep. 2002. PMID: 11895621 Review.
-
ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential.Pharmaceuticals (Basel). 2021 Jul 8;14(7):655. doi: 10.3390/ph14070655. Pharmaceuticals (Basel). 2021. PMID: 34358081 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical